Hyderabad: The Genome Valley Excellence Award 2026 will be conferred upon Dr Bruce Levine of the University of Pennsylvania's ...

Scientists uncover a new “recipe” that shows how exhausted T cells can be reprogrammed to regain their ability to attack tumors.

Company remains the only organisation globally dedicated exclusively to the research, development, manufacturing and ...

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions.

Engineering regulatory T cells (Tregs) has emerged as a powerful strategy to achieve durable, antigen-specific immune tolerance for autoimmune and ...

As part of the collaboration, RegCell will transfer its lead Treg program to Kincell Bio for process and analytical transfer and development, optimization of a scalable manufacturing process, and GMP ...

While the broader market remains fixated on Waaree Energies, a quieter growth story is unfolding within its own orbit. Two of its subsidiaries have been operating in the shadows of their parent and ...

The deal gets Lilly access to Orna’s in vivo CAR T technology. The biotech’s lead asset, which has yet to start clinical ...

Eli Lilly reinforced its push into next-generation immunology and oncology innovation through two major transactions: the ...

Century Therapeutics (IPSC) aims at a durable “once-and-done” Type 1 diabetes cure with hypoimmune iPSC beta cells; runway to 2029—click here to read now.

IN8bio (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (?d) T cell therapies and T cell engagers for cancer and ...